Thank you for the submission of your manuscript to EMBO reports. We have just now received the full set of reports from the referees, which I copy below. As all three referees think that your manuscript is interesting and their comments are quite positive, I would like to ask you to revise it according to the referees' comments.
In their reports, all three referees remark that the binding of the ChAM domain on its own to DNA or chromatin needs to be addressed experimentally. Referees #2 and #3 suggest some experiments in this direction. This is the most problematic point of the manuscript and must be addressed. Referee #2 raises also some issues concerning your experimental data and referee #3 considers that some of the evidence you show needs further explanation.
Given the referees evaluations and the potential interest of your study, I would like to give you the opportunity to revise your manuscript, with the understanding that the referee concerns must be fully addressed and their suggestions (as detailed above and in their reports) taken on board. Acceptance of the manuscript will depend on a positive outcome of a second round of review and I should also remind you that it is EMBO reports policy to allow a single round of revision only and that, therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript.
I look forward to seeing a revised version of your manuscript when it is ready.
Yours sincerely, Editor EMBO reports REFEREE REPORTS:
This study utilizes protein sequence analysis to reveal a conserved domain in PABL2 that is important for chromatin association and DNA repair function. The authors name this conserved domain named as ChAM. A region encompassing ChAM had been previously implicated in DNA binding. The results are convincing and the work does add some insight into PalB2 function. However, more insight into ChAM would be required to move the manuscript beyond description. Specific points: 1. What DNA structures does ChAM recognize? 2. ChAM point mutant analysis and DNA binding would enhance the sudy. 3. What is the relative contribution of ChAM to PalB2 damage localization in comparison to PalB2 association with BRCA1?
Referee #2:
In this paper, Bleuyard and Esashi show that the conserved ChAM motif is important for PALB2 chromatin association in unperturbed cells. Furthermore, the absence of PALB2 ChAM domain renders cells to be sensitive to MMC or Olaparib treatment. Below are some points that merit much further strengthening. Unfortunately, although the experiments conducted are mostly well performed, I feel that the manuscript is preliminary at this stage for publication in EMBO reports.
1. Figure 1 and 2: "The conserved ChAM motif is located within the N-terminal part of PALB2 DNA-binding region II". A key question would be to test whether the ChAM motif can bind DNA on its own.
It is not clear whether the PAL2DeltaChAM phenotypes are due to defective DNA binding or chromatin binding. Does PALB2Delta DNA binding 2, recapitulate the results presented ? 2. Conversely, does PALB2 Delta ChAM still binds DNA? One possibility is that the deletion of this region affects severely the folding of the PALB2 protein, leading to a severely impaired PALB2 in terms of DNA binding. Consequently, this would affect cell survival in the presence of genotoxic agents.
3. Figure 2 : The chromatin association of PALB2 or PALB2 DeltaChAM must also be performed in the presence of ionizing radiation and mitomycin C.
4. Figure 2 . What happens to endogenous PALB2 under these conditions ? 5. Figure 2A (lanes 4 and 8) and Figure S2C : It is not clear why there is less BRCA1 in the nuclear soluble fraction or chromatin fraction when PALB2 DeltaChAM is overexpressed. Perhaps the phenotypes they observed in Figure 3 are related to that observation ? 6. Figure 2B lanes 5-6 and Figure S2D lanes 17-18: It is not clear why there is a decrease of PALB2 DeltaChAM in the nuclear soluble fraction in the presence of siMRG15.
7. Figure 2B lanes 9-12 and Figure S2D lanes 21-24: When PALB2 is overexpressed there is no impact on BRCA1 levels in the absence/presence of siMRG15 (lanes 9-10). When PALB2 DeltaChAM is overexpressed there is a decrease of BRCA1 (lane 11) but the levels of BRCA1 are rescued in the presence of siMRG15 (lane 12). Could the authors comment on this result ?
In addition, it would also be important to test whether the overexpression of MRG15, compensate for the loss of ChAM.
8. Figure 3 : Because the decrease of PALB2 foci is weak when the ChAM motif is removed, the authors must confirm this result by other methods. The number of BRCA2 and RAD51 foci should be scored in the presence of PALB2 or PALB2 Delta ChAM motif. 9. The authors should also show representative immunofluorescence pictures for all quantifications. 10. To get a more complete picture of the roles of ChAM, the levels of homologous recombination should be scored with the Jasin system in PALB2, PALB2 deltaChAM. 11. The authors should also look at the accumulation of DSBs by comet assay or PFGE.
Finally, The paper would be much more complete if the authors were to express the ChAM domain on its own and see whether it binds DNA, chromatin, and affects the cellular sensitivity to DNA damaging agents. Also, The relationship with MRG15 is interesting, but it needs to be better documented.
Minor points. Figure 2B . There is a non-specific band on the RAD51 blot that disappears concomitantly with MRG15 knockdown. Is this phosphorylated RAD51 ? The Lamin A blot is missing from panel 2B.
Referee #3:
Reviewed Manuscript: ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding, is critical for DNA repair
The authors present a manuscript describing the identification of a putative chromatin-association module in the protein PALB2.
They show through a series of biochemical and cellular experiments that a PALB2 deletion mutant, which retains it interactions with known protein partners (BRCA2, BRCA1, MRG15 and Rad51), is no longer found in the chromatin fraction derived from cellular extracts. They also demonstrate that when the deletion mutant is expressed in a PALB2-null cell line (EUFA1341) it is unable to rescue MMC sensitivity, unlike when the wild-type protein is reintroduced. PALB2deltaChAM complemented EUFA cells also show intermediate sensitivity to the PARP inhibitor Olaparib.
Overall, I think the manuscript is of a good standard, and with some revision could certainly be considered for publication.
One critical and essential experiment does however seem to be missing from the paper -namely, distinguishing whether the declared "Chromatin Association Module" of PALB2 binds directly to histones and or nucleosomes, as opposed to the already identified DNA-binding potential of this region (see cited references Buisson et al, 2010 and Dray et al, 2010) .
As they stand, the presented data do not distinguish whether the presence of PALB2 in the chromatin-associated fraction is actually just due to the previously demonstrated interaction of PALB2 with DNA, or via a direct / indirect (i.e. through a hereto unknown protein partner) association with chromatin itself.
One relatively simple way to address this particular question, could be to over-express just the ChAM region of PALB2 in cells, and demonstrate via a co-IP experiment (using for example an anti-H3 antibody) that this region is bound/associated with chromatin. The authors may be also be able to think of more elegant ways to demonstrate a direct chromatin association -but this is a point, I feel, that does need to be fully addressed in a revised manuscript.
>> Some additional points to consider / address:
1) It is not clear why the authors have used EYFP-PALB2 and / or FE-PALB2 in their experimental series. A simple short paragraph explaining the reasoning behind the two different fusions may well assist the reader in interpreting the experimental data -i.e. any particular issues or problems with each fusion-type. In particular, why have the FE-tagged versions been used in the foci experiments presented in Figure 3A -where a more obvious choice would have been the EYFP-fusion for direct fluorescence imaging? Similarly, why were the EYFP-tagged versions used in the MMC / Olaparib sensitivity assays, over the FE-tag? Some clarification would be useful here.
2) Non-specific bands should be indicated for the panels presented in Fig 1C ( as they are in the other figures).
3) In Figure 2A it is particularly difficult to distinguish the non-specific bands from the specific band in the EYFP-PALB2 blots (particularly lane 4). Figure 2A -why is there a reduction in the amount of BRCA2 in the nuclear soluble fraction for the vector control, compared to the non-transfected (-) cells? 5) Similarly, which is the non-specific band for Rad51 in the Figure 2B / chromatin-enriched western blot? In Figure 2A , the non-specific band is found running higher than Rad51, and is present in all the samples analysed (lanes 5/6/7/8). However, in Figure 2B , it is the lower band that is present in all the samples analysed (lanes 7-12) and it is the top-band that varies in intensity -is this 'non-specific' band is actually related to MRG15, as is seems to disappear in the siRNA treated samples.
4) Also in
6) The BRCA1 blots in Fig 2B are particularly poor, especially when compared to those presented in Figure 2A . 7) How were PALB2 foci scored in the immuno-fluorescence experiments presented in Figure 3A as there appears to be a lot of non-specific background in these images -a short sentence or paragraph in the Materials and Methods would be useful here. 8) Page 6 -the authors state that "ChAM-mediated chromatin association of PALB2 is crucial for cellular resistance to MMC, whilst it appears dispensable for the repair of Olaparib-induced DNA lesions". However, re-introduction of PALB2-deltaChAM into EUFA only partially rescues Olaparib sensitivity -therefore the statement that it is "dispensible" is not correct. The authors should rephrase this sentence accordingly. Answers to referees' comments
This study utilizes protein sequence analysis to reveal a conserved domain in PABL2 that is important for chromatin association and DNA repair function. The authors name this conserved domain named as ChAM. A region encompassing ChAM had been previously implicated in DNA binding. The results are convincing and the work does add some insight into PalB2 function. However, more insight into ChAM would be required to move the manuscript beyond description. Specific points:
1. What DNA structures does ChAM recognize?
We have performed extensive analysis using recombinant ChAM and a PALB2 mutant with an internal ChAM deletion (PALB2 Delta ChAM; Figures 3A , B, C, and S3). The results show that ChAM itself has little or no DNA binding activity, while PALB2 Delta ChAM exhibited binding activity both to ssDNA and D-loop structures that was similar to that of full length PALB2.
2.
ChAM point mutant analysis and DNA binding would enhance the study.
As ChAM does not bind DNA, we did not extend our analyses to ChAM point mutants.
3.
What is the relative contribution of ChAM to PalB2 damage localization in comparison to PalB2 association with BRCA1?
As shown in figure 4E , we have found that PALB2 localization is significantly reduced following BRCA1 down-regulation. We propose that ChAM plays an important role in PALB2 chromatin association in unperturbed cells and/or during DNA repair, but relatively minor roles in damageinduced re-localization. This point is extensively discussed in the revised manuscript.
It is not clear whether the PAL2DeltaChAM phenotypes are due to defective DNA binding or chromatin binding. Does PALB2Delta DNA binding 2, recapitulate the results presented?
As stated above and shown in Figures 3A, B , C, and S3, we have found no DNA binding with the ChAM domain, but strong chromatin (or nucleosome) binding activity was detected (Figures 4E, F and G). We conclude that the phenotypes associated with Delta ChAM are due to defective chromatin binding.
2. Conversely, does PALB2 Delta ChAM still binds DNA? One possibility is that the deletion of this region affects severely the folding of the PALB2 protein, leading to a severely impaired PALB2 in terms of DNA binding. Consequently, this would affect cell survival in the presence of genotoxic agents.
Indeed, PALB2 Delta ChAM still binds DNA, with a marked preference for ssDNA and D-loop HR intermediate structures, similar to wild-type full length PALB2 ( Figures 3A, B , C, and S3). Delta ChAM also binds to all known binding partners (BRCA2, BRCA2, MRG15 and Rad51; Figures 1C  and S2A ), hence it is unlikely that the mutant protein is misfolded.
3. Figure 2 : The chromatin association of PALB2 or PALB2 Delta ChAM must also be performed in the presence of ionizing radiation and mitomycin C.
The results are shown in Figure 2A and S2B. The total amount of PALB2 protein (either wild type or Delta ChAM) was unchanged or modestly decreased in response to both IR and MMC treatment. We recognize that fractionation cannot address protein accumulation at DNA damage sites (as opposed to bulk chromatin binding), while our foci analyses support the notion that PALB2 accumulates at DNA damage sites (marked by gH2AX), partly but significantly in a ChAMdependent manner.
4. Figure 2 . What happens to endogenous PALB2 under these conditions?
Given the size of PALB2 protein (131 kDa) and the amount of exogenously expressed tagged PALB2, it was difficult to detect endogenous PALB2 in this assay. We think this is due to slightly less sample loading in this lane; we now include a Lamin A blot in the panel to serve as a loading control.
7. Figure 2B lanes 9-12 and Figure S2D lanes 21-24: When PALB2 is overexpressed there is no impact on BRCA1 levels in the absence/presence of siMRG15 (lanes 9-10). When PALB2 DeltaChAM is overexpressed there is a decrease of BRCA1 (lane 11) but the levels of BRCA1 are rescued in the presence of siMRG15 (lane 12). Could the authors comment on this result?
Similarly to point 6, we think this is due to less sample loading on this lane, while the difference is very small. We now include a Lamin A blot in the panel, and a longer exposure of the BRCA1 blot.
We have examined whether MRG15 overexpression modified chromatin binding of PALB2 Delta ChAM ( Figures 2B and S2A ), and indeed a modest restoration of deltaChAM chromatin binding was found after MRG15 overexpression. This point is discussed in the revised manuscript.
8. Figure 3 : Because the decrease of PALB2 foci is weak when the ChAM motif is removed, the authors must confirm this result by other methods. The number of BRCA2 and RAD51 foci should be scored in the presence of PALB2 or PALB2 Delta ChAM motif.
We have assessed Rad51 foci as requested. As shown in Figure 4D , Rad51 foci decrease to the same extent as Delta ChAM.
9. The authors should also show representative immunofluorescence pictures for all quantifications.
The pictures are now included in the supplemental material ( Figure S4A , B and C).
10. To get a more complete picture of the roles of ChAM, the levels of homologous recombination should be scored with the Jasin system in PALB2, PALB2 deltaChAM.
We experienced technical difficulties in attempting to generate stable PALB2-defective EUFA 1341 cell lines both stably expressing PALB2 variants and carrying the Jasin HR reporter gene. Also EUFA 1341 cells appeared to be very sensitive to transient DNA transfection, which would make it difficult to express I-SceI endonuclease. Nonetheless, its role in HR is suggested in newly added Figure 4D , wherein Rad51 focus formation is impaired in Delta ChAM cells. We establish that the ChAM domain is important for the DNA damage response, in particular for focal accumulation of PALB2 and Rad51 at damage sites; its precise impact on HR repair will be addressed in future work.
11. The authors should also look at the accumulation of DSBs by comet assay or PFGE.
As indicated above under point 10, we have performed Rad51 foci analysis, and the relationship between ChAM deletion and Rad51 accumulation was established. It is well documented that Rad51 focus formation is critical for DSB repair, hence we concluded that DSB repair is partly defective in Delta ChAM cells.
As is now shown in Figures 3D and E, our analyses clearly show that exogenously expressed ChAM domain accumulates in the nuclei and binds chromatin on its own. Despite no evidence that ChAM binds either DNA or histones, we found clear interaction between ChAM and nucleosomes ( Figure  3F and G). This finding provided depth to our study, discriminating the molecular mechanism of PALB2 chromatin binding from its binding to damaged DNA and HR intermediates. Additionally, we now have preliminary data suggesting that ChAM overexpression results in a very mild (~20%) reduction of HR efficiency using the Jasin tandem GFP system (Esashi, not shown). However, we found that chromatin association of endogenous PALB2, BRCA2 or Rad51 was not significantly affected following ChAM overexpression ( Figure 3E) ; given the robust nucleosome binding activity of ChAM, we are cautious to conclude that the HR phenotypes seen on ChAM overexpression are associated with a dominant negative effect, but it seems likely that its nucleosome binding activity could influence general DNA metabolism.
Minor points. Figure 2B . There is a non-specific band on the RAD51 blot that disappears concomitantly with MRG15 knockdown. Is this phosphorylated RAD51 ?
Indeed, this band is MRG15 (41kda), rather than Rad51 (37kDa), due to the re-blotting procedure used for this blot (i.e. it was first incubated with rabbit antibody against MRG15 and, following treatment of the membrane with Millipore ReBlot Mild antibody stripping solution, blotted with rabbit antibody for Rad51). We understand the confusion however, and have now replaced this panel with a fresh Rad51 blot of the same samples. The Lamin A blot is missing from panel 2B.
A lamin A blot is now included Referee #3:
Reviewed Manuscript: ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding, is critical for DNA repair The authors present a manuscript describing the identification of a putative chromatin-association module in the protein PALB2.
One critical and essential experiment does however seem to be missing from the paper&#x00A0;namely, distinguishing whether the declared "Chromatin Association Module" of PALB2 binds directly to histones and or nucleosomes, as opposed to the already identified DNA-binding potential of this region (see cited references Buisson et al, 2010 and Dray et al, 2010) .
We appreciate the comments and suggestions. As covered in our response to Referee 2's final point, our analyses shown in Figures 4D, E , F and G demonstrate that exogenously expressed ChAM binds chromatin. Further, our pull-down experiment showed clear binding to nucleosomes (~160 bp DNA wrapped around a core histone octamer).
Plasmids carrying FE (FLAG and EGFP) tag are compatible with the Flp-in site-specific integration system, and were used to generate stable cell lines using 293 Flp-in and HT1080 Flp-in parental cells, where tagged alleles can be expressed from a common genomic locus. The EYFP tag was used for random integration in the EUFA1341 PALB2 defective cell line, where the neomycin resistance gene on the plasmid backbone was used to assist selection of stable cell lines. Unfortunately, neither EYFP nor EGFP (from the FE-tag) could be detected by direct fluorescence, and the PALB2 localization was detected by indirect immunofluorescence using a GFP antibody. These points are now clarified in materials and methods section.
They are now labeled clearly.
3) In Figure 2A it is particularly difficult to distinguish the non-specific bands from the specific band in the EYFP-PALB2 blots (particularly lane 4).
We have updated the blot presented in Figure 2A . The intensity of the specific band is stronger (especially in lanes 19-36) and we think there is no longer any confusion with the non-specific band. Figure 2A -why is there a reduction in the amount of BRCA2 in the nuclear soluble fraction for the vector control, compared to the non-transfected (-) cells?
4) Also in
The transfected cells have been grown under G418 selection, which might have influence the amount of BRCA2 in the absence of PALB2. The observation is interesting, but we don't think this is important for the present study. More comprehensive fractionation analyses are now provided in Figures 2 and S2. 5) Similarly, which is the non-specific band for Rad51 in the Figure 2B / chromatin-enriched western blot? In Figure 2A , the non-specific band is found running higher than Rad51, and is present in all the samples analysed (lanes 5/6/7/8). However, in Figure 2B , it is the lower band that is present in all the samples analysed (lanes 7-12) and it is the top-band that varies in intensity -is this 'non-specific' band is actually related to MRG15, as is seems to disappear in the siRNA treated samples.
It is indeed MRG15, and is now replaced with a fresh Rad51 blot (See our response to referee 2's minor point for Figure 2B) 6) The BRCA1 blots in Fig 2B are particularly poor, especially when compared to those presented in Figure 2A . This is now replaced with a longer exposure of the BRCA1 blot. 7) How were PALB2 foci scored in the immuno-fluorescence experiments presented in Figure 3A as there appears to be a lot of non-specific background in these images -a short sentence or paragraph in the Materials and Methods would be useful here.
Higher quality images are now presented in figure S4A , B, C. Our immunofluorescence gives clear and specific foci, and is clearly distinguishable from background staining under the microscope. The scoring method is now stated in the text. 8) Page 6 -the authors state that "ChAM-mediated chromatin association of PALB2 is crucial for cellular resistance to MMC, whilst it appears dispensable for the repair of Olaparib-induced DNA lesions". However, re-introduction of PALB2-deltaChAM into EUFA only partially rescues Olaparib sensitivity -therefore the statement that it is "dispensible" is not correct. The authors should rephrase this sentence accordingly.
We appreciate this comment, and the text has now been amended accordingly. I am very pleased to accept your manuscript for publication in the next available issue of EMBO reports. Thank you for your contribution to our journal.
As you will see below, the manuscript was sent to two of the former referees and both agree that your revised manuscript is much improved. Although they make some observations, I do not consider that any further action is needed and I am including their comments for your records. Naturally, if you would like to add anything to your report in response to these comments, you are welcome to do it.
Thank you again for your contribution to EMBO reports and congratulations on a successful publication. Please consider us again in the future for your most exciting work.
Yours sincerely, Editor EMBO Reports REFEREE REPORTS:
Referee #1
The authors have produced a revised manuscript that largely addresses all of the reviews' concerns. They show additional evidence that ChAM is an important element of PalB2 dependent chromatin association and provide new data that ChAM binds nucleosomes, not DNA. The paper should be of general interest to the DNA repair community. An interesting yet unexplained finding is that ChAM is more heavily required for responses to MMC than Olaparib. Although I do not expect the authors to solve this issue entirely, it would be informative to compare radial chromosome formation in response to MMC and olaparib in cells expressing wt vs delta ChAM. This may lend some insight into the differences in drug sensitivity. Otherwise, this study provides description of a new domain in PalB2 and some new insight into how PalB2 functions. in HRR. It is a nice contribution.
Referee #3
EMBOR-2011-35193V2: ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair Overall, the authors have answered my points and comments satisfactorily. I would now recommend that the manuscript be accepted for publication in EMBO Reports.
However, there are still a couple of minor points that may need addressing, but I leave this to the Editor's discretion as to whether they require following up. a) Figure 2 , panel A; EUFA1341 cells.
Why is the H2A.X blot blank in the whole cell extract blots? Especially as H2A.X is visible in panel C, in blots against HT1080 cells. b) Figure 3 , panel D; Fluorescence microscopy images of GFP and GFP-ChAM expressed in HEK293T cells.
I'm not sure that the images presented, actually support the statement made in the main text of the manuscript: "Fluorescence microscopy revealed that, in contrast to the diffuse cellular localization of GFP alone, ChAM is sufficient to target the GFP fusion to the nuclear compartment." To my eyes, some of the GFP encoded by pDEST53 is indeed cellular, but in the merged image, some of it also looks nuclear as demonstrated by co-localisation with the DAPI stain. Also, this doesn't look all that much different from the images presented for the pDEST53-ChAM construct. Do the authors have a clearer set of images to present?
